Revolutionising precision oncology: new biomarker identification with 1-day NGS
Biomarker testing in precision oncology: a European revolution
Even in these hard times, our thought leaders virtually presented their experiences with our Oncomine™ NGS solutions in the most important European national pathology congresses. Have you missed the opportunity to join us in one of our satellite symposia during 2021?
Now you have the possibility to access all our on-demand content in local language and discover how NGS can be as fast and easy as IHC allowing your lab to test latest and established relevant biomarkers in a single day.
Choose the topic you are interested the most to learn more on:
Discover how to deliver NGS results at the same time as other single-gene methods with the Ion Torrent™ Genexus™ System.
Prof. Fernando Lopez-Rios, Universidad CEU San Pablo, Spain
Prof. Michael Hummel, Charité CCC, Germany
Dr. Hana Lango Allen, East Genomic Laboratory Hub, UK
Dr. Reiltin Werner, Cork University Hospital, Ireland
Dr. Javier Hernandez Losa, Director of Molecular Biology Laboratory, Pathology Department, Vall d'Hebron University Hospital, Spain
Listen to European oncologists and learn from them how NGS based molecular characterisation of tumour samples will provide a rational and highly promising approach for guiding oncologists in treatment decision-making.
Prof. Mariano Provencio, Hospital Universitario Puerta de Hierro, Spain
Dr. Francesco Passiglia, University of Turin, Italy
Gain more detailed insights faster with the complete Oncomine solid tumour NGS workflow solution. Listen to our users and discover our broad assay menu from targeted to comprehensive genomic profiling, with the smallest sample input requirements in the industry. Learn from them how to analyse more samples and produce complete bioinformatic reports that drive key insights.
Dr. Yolanda Ruano Dominguez, Hospital 12 de Octubre, Spain
Dr. Massimo Barberis, Istituto Europeo di Oncologia, Italy
Prof. Dr. Peter Wild, Director of Dr. Senckenberg Institute for Pathology, University Hospital Frankfurt, Germany
Dr. Massimo Barberis, Director of Histopathology and Molecular Diagnostics Unit, European Institute of Oncology, Italy
Ilaria Alborelli, PhD, Clinical Data Analyst, Institute of Pathology and Medical Genetics, University Hospital Basel, Switzerland
For Research Use only. Not for use in diagnostic procedures.